Last year, health systems around the world continued facing crises—conflicts in the Middle East and Sudan intensified medicine shortages and widened gaps in access to lifesaving care.
Climate-driven outbreaks of anthrax and other deadly diseases spread from animals to humans, and antimicrobial-resistant superbugs continued to threaten local and global health.
Thanks to your support, our experts were able to respond to these threats, create disease surveillance systems, train thousands of community health workers, integrate multiple health services into single points of care, and so much more.
Transgender-competent health care in Vietnam has historically been inaccessible or unavailable. USAID/PATH Healthy Markets and its partners addressed these barriers to care through innovative interventions.
Malawi has a staggering typhoid burden, with surveillance data showing 444 cases per 100,000 people per year. To address this, Malawi launched the typhoid conjugate vaccine with the aim of reaching more than 9 million children.
Hypertension is still the leading risk factor for cardiovascular disease—the main cause of death globally. PATH collaborated with the Ministry of Health and AstraZeneca to expand screenings for hypertension and transform cardiovascular care.
Bangladesh rolled out a nationwide human papillomavirus vaccination (HPV) campaign. Upon completion, the HPV vaccine is expected to be added to the country’s routine immunization schedule.
Counseling for drug-sensitive tuberculosis (TB) serves as a bridge between medical treatment and the patient’s emotional well-being. In Myanmar, PATH strengthened counseling support for TB patients.
PATH partnered with the Ugandan government to detect and prevent zoonotic diseases caused by climate change—and protect farmers and their animals.
Everyone deserves the chance to live a healthy life.
Your ongoing support, big or small, allows us to plan ahead and meet the unexpected needs of communities around the world.